ovarian cancer news
A new study by McGill University’s Division of Cancer Epidemiology will test a revolutionary way of preventing the transmission of the human papillomavirus (HPV) through the use of a topical gel applied during sexual activity.
A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease. A multi-disciplinary team led by the Research Institute of the McGill University Health Centre (RI MUHC), in collaboration with the Lady Davis Institute of the Jewish General Hospital and the University of Montreal Hospital Research Centre, has identified genetic patterns in ovarian cancer tumours that help to differentiate patients based on the length of their survival after initial surgery. The study was published in the journal PLOS ONE.